Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis.
暂无分享,去创建一个
D. Wheeler | M. Davies | J. Williams | G. Thomas | R. Chana
[1] M. Daha,et al. Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. , 1996, Kidney international.
[2] R. Mason,et al. Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. , 1995, Kidney international.
[3] R. Mason,et al. Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. , 1994, The Biochemical journal.
[4] M. Davies,et al. The source and possible significance of hyaluronan in the peritoneal cavity. , 1994, Kidney international.
[5] D. Wheeler,et al. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. , 1994, Kidney international.
[6] Rosenblum Nd,et al. The mesangial matrix in the normal and sclerotic glomerulus. , 1994 .
[7] J. Couchman,et al. Glomerular matrix: synthesis, turnover and role in mesangial expansion. , 1994, Kidney international.
[8] A. Yayon,et al. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. , 1994, The Journal of biological chemistry.
[9] N. Rosenblum. The mesangial matrix in the normal and sclerotic glomerulus. , 1994, Kidney international. Supplement.
[10] P. Vijayagopal. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. , 1993, The Biochemical journal.
[11] H. van Goor,et al. Renal apolipoproteins in nephrotic rats. , 1993, The American journal of pathology.
[12] B. Kasiske,et al. Hypertension, hyperlipidemia, and renal damage. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] D. Wheeler,et al. Interactions between lipoproteins, glomerular cells and matrix. , 1993, Mineral and electrolyte metabolism.
[14] E. Ruoslahti,et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.
[15] N. Kashihara,et al. Modulation of glomerular proteoglycans by insulin-like growth factor-1. , 1992, Kidney international.
[16] R. Mason,et al. Mesangial cell proteoglycans: synthesis and metabolism. , 1992, Journal of the American Society of Nephrology : JASN.
[17] E. Schönherr,et al. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.
[18] R. Mason,et al. Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture. , 1991, The Biochemical journal.
[19] R. Mason,et al. Human glomerular epithelial cell proteoglycans. , 1990, Archives of biochemistry and biophysics.
[20] S. Srinivasan,et al. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. , 1989, Biochimica et biophysica acta.
[21] S. Klahr,et al. Progression of renal disease. , 1988, Seminars in nephrology.
[22] S. Klahr,et al. The progression of renal disease. , 1989, The New England journal of medicine.
[23] R. Mason,et al. Renal glomerular proteoglycans. An investigation of their synthesis in vivo using a technique for fixation in situ. , 1988, The Biochemical journal.
[24] R W Farndale,et al. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.
[25] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[26] U. K. Laemmli,et al. Cleavage of structural proteins during , 1970 .